About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 283425, 6 pages
http://dx.doi.org/10.1155/2013/283425
Research Article

The Investigation of Tramadol Dependence with No History of Substance Abuse: A Cross-Sectional Survey of Spontaneously Reported Cases in Guangzhou City, China

1School of Public Health, Peking University, Beijing 100191, China
2National Institute on Drug Dependence, Peking University, 38 Xueyuan Road Haidian District, Beijing 100191, China

Received 10 April 2013; Revised 14 July 2013; Accepted 14 August 2013

Academic Editor: Eiichi Kumamoto

Copyright © 2013 Haoran Zhang and Zhimin Liu. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Gillen, M. Haurand, D. J. Kobelt, and S. Wnendt, “Affinity, potency and efficacy of tramadol and its metabolites at the cloned human μ-opioid receptor,” Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 362, no. 2, pp. 116–121, 2000. View at Publisher · View at Google Scholar · View at Scopus
  2. L. Radbruch, S. Grond, and K. A. Lehmann, “A risk-benefit assessment of tramadol in the management of pain,” Drug Safety, vol. 15, no. 1, pp. 8–29, 1996. View at Scopus
  3. WHO Expert Committee on Drug Dependence, Twenty-Eighth Report, WHO, Geneva, Switzerland, 1992.
  4. WHO Expert Committee on Drug Dependence, Thirty-Second Report, WHO, Geneva, Switzerland, 2000.
  5. WHO Expert Committee on Drug Dependence, Thirty-Third Report, WHO, Geneva, Switzerland, 2002.
  6. WHO Expert Committee on Drug Dependence, Thirty-Fourth Report, WHO, Geneva, Switzerland, 2006.
  7. SFDA, “Narcotic drugs and psychotropic drugs directory,” 7th version, 2008.
  8. SFDA, “National drug abuse monitoring center,” Annual Report of National Drug Abuse, 2009.
  9. SFDA, “National drug abuse monitoring center,” Annual Report of National Drug Abuse, 2010.
  10. SFDA, “National drug abuse monitoring center,” Annual Report of National Drug Abuse, 2011.
  11. SFDA, “National drug abuse monitoring center,” Annual Report of National Drug Abuse, 2012.
  12. Center for ADR Monitoring of Guangdong Province, “It is more terrable for analgesic addiction,” 2006, http://news.sina.com.cn/c/h/2006-09-19/162511050122.shtml.2006-09-19.
  13. H. F. Miranda and G. Pinardi, “Antinociception, tolerance, and physical dependence comparison between morphine and tramadol,” Pharmacology Biochemistry and Behavior, vol. 61, no. 4, pp. 357–360, 1998. View at Publisher · View at Google Scholar · View at Scopus
  14. J. E. Sprague, M. Leifheit, J. Selken, M. M. Milks, D. H. Kinder, and D. E. Nichols, “In vivo microdialysis and conditioned place preference studies in rats are consistent with abuse potential of tramadol,” Synapse, vol. 43, no. 2, pp. 118–121, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Zhang, L. Jing, Q. Liu, et al., “Tramadol induces conditioned place preference in rats: interactions with morphine and buprenorphine,” Neuroscience Letters, vol. 520, no. 1, pp. 87–91, 2012.
  16. K. L. Preston, D. R. Jasinski, and M. Testa, “Abuse potential and pharmacological comparison of tramadol and morphine,” Drug and Alcohol Dependence, vol. 27, no. 1, pp. 7–17, 1991. View at Publisher · View at Google Scholar · View at Scopus
  17. M. D. Vickers, D. O'Flaherty, S. M. Szekely, M. Read, and J. Yoshizumi, “Tramadol: pain relief by an opioid without depression of respiration,” Anaesthesia, vol. 47, no. 4, pp. 291–296, 1992. View at Scopus
  18. R. J. Leo, R. Narendran, and B. Deguiseppe, “Methadone detoxification of tramadol dependence,” Journal of Substance Abuse Treatment, vol. 19, no. 3, pp. 297–299, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Shadnia, K. Soltaninejad, K. Heydari, G. Sasanian, and M. Abdollahi, “Tramadol intoxication: a review of 114 cases,” Human and Experimental Toxicology, vol. 27, no. 3, pp. 201–205, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. J. E. Sprague, M. Leifheit, J. Selken, M. M. Milks, D. H. Kinder, and D. E. Nichols, “In vivo microdialysis and conditioned place preference studies in rats are consistent with abuse potential of tramadol,” Synapse, vol. 43, no. 2, pp. 118–121, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. Z.-M. Liu, W.-H. Zhou, Z. Lian et al., “Drug dependence and abuse potential of tramadol,” Acta Pharmacologica Sinica, vol. 20, no. 1, pp. 52–54, 1999. View at Scopus
  22. E. C. O'Connor and A. N. Mead, “Tramadol acts as a weak reinforcer in the rat self-administration model, consistent with its low abuse liability in humans,” Pharmacology Biochemistry and Behavior, vol. 96, no. 3, pp. 279–286, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. T. J. Cicero, E. H. Adams, A. Geller et al., “A postmarketing surveillance program to monitor ultram (tramadol hydrochloride) abuse in the united states,” Drug and Alcohol Dependence, vol. 57, no. 1, pp. 7–22, 1999. View at Publisher · View at Google Scholar · View at Scopus
  24. B. Dew, K. Elifson, and M. Dozier, “Social and environmental factors and their influence on drug use vulnerability and resiliency in rural populations,” Journal of Rural Health, vol. 23, no. 1, supplement, pp. 16–21, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Fletcher, C. Bonell, and J. Hargreaves, “School effects on young people's drug use: a systematic review of intervention and observational studies,” Journal of Adolescent Health, vol. 42, no. 3, pp. 209–220, 2008. View at Publisher · View at Google Scholar · View at Scopus